In patients with 3 or more positive sentinel lymph nodes who get a SLNB only, do you advocate for an ALND even if you are planning to treat their regional nodes regardless?
These patients were not eligible for Z0011 and represents less than 5% of the patient population in AMAROS. Thus, can you apply these two trials to justify omission of a dissection in these patients when treating with RNI?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on
Although they were underrepresented in AMAROS study, in reality a scenerio like this is so uncommon that it would be hard to have any prospective study. We do not push for dissection if pre surgery imaging and clinical exam was consistent with NO disease and plan these patients with comprehensive no...
Join for free or sign in to see the full answer